[Inborn errors of metabolism with neurological manifestations in the neonatal period].

Congenital metabolic diseases are considered as rare diseases because of their low incidence and their clinical symptoms at onset. Sometimes they can just begin in the neonatal period. Their progressive knowledge and the availability of specific and sensitive biochemical procedures allow us to diagnose many congenital metabolic diseases, which were not recognized some years ago. We reviewed the 52 patients with congenital metabolic diseases diagnosed during the last 25 years in our centre, evaluating the clinical presentation, neurological symptoms, complementary exams and clinical evolution. The mean age at onset of symptoms was 5 days and the mean age at diagnosis was 88 days of age. We considered a first group of 36 patients with inborn errors of intermediary metabolism, in whom hypotonia, weight loss and seizures are the main symptoms. The second group was composed of 8 patients with defective energy metabolism, who showed abnormal respiratory rhythm and hypotonia. Finally, we considered 8 patients with diseases of the complex molecules, who presented with hypotonia and cataracts as common symptoms at onset. The more common neurological symptoms in this period were hypotonia (60%), sensorial deficit (35%) and refractory seizures (23%). The complementary laboratory tests in the first phases of the diseases allowed us to suspect a congenital metabolic disease especially among intermediary and energy defects. EEG and CSF samples were important to diagnose some inborn errors of intermediary metabolism. In the first steps, the neuroimaging was less orientative, even if it allow the exclusion of other diseases. More than half of the patients with inborn errors of metabolism with onset in the neonatal period died within the first two years of life. It is really important to suspect these diseases in the neonatal period so as to achieve an early diagnosis and prompt therapy, specially with cofactors, that can reduce the morbimortality.

[1]  W. Blom,et al.  A clinical biochemist's view of the investigation of suspected inherited metabolic disease , 1989, Journal of Inherited Metabolic Disease.

[2]  H. Bremer,et al.  Neurological manifestations of organic acid disorders , 2005, European Journal of Pediatrics.

[3]  J. Leonard.  The early detection and management of inborn errors presenting acutely in the neonatal period , 1985, European Journal of Pediatrics.

[4]  S. Heales,et al.  Neonatal epileptic encephalopathy , 2003, The Lancet.

[5]  H. O. Baulny.  Management and emergency treatments of neonates with a suspicion of inborn errors of metabolism , 2002 .

[6]  Huei-Shyong Wang,et al.  Pyridoxal phosphate-responsive epilepsy with resistance to pyridoxine. , 2002, Pediatric neurology.

[7]  J. Saudubray,et al.  Clinical approach to inherited metabolic disorders in neonates: an overview. , 2002, Seminars in neonatology : SN.

[8]  Y. Toribe.  High-dose vitamin B6 treatment in West syndrome , 2001, Brain and Development.

[9]  A. Morris,et al.  Inborn errors of metabolism around time of birth , 2000, The Lancet.

[10]  J. C. Plana.  Síndromes epilépticos del primer año de vida y errores congénitos del metabolismo , 2000 .

[11]  K. Hyland,et al.  Folinic Acid-Responsive Neonatal Seizures , 1999, Journal of child neurology.

[12]  J. Fernández,et al.  Manifestaciones epilépticas de causa metabólica , 1999 .

[13]  J. Campistol.  [Approximation to the diagnosis of congenital metabolic disorders with neuroimaging]. , 1999, Revista de neurología (Ed. impresa).

[14]  J. Saudubray,et al.  Inborn Metabolic Diseases: Diagnosis and Treatment , 1995 .

[15]  K. Roth.  Inborn Errors of Metabolism: The Essentials of Clinical Diagnosis , 1991, Clinical pediatrics.

[16]  Charles R.scriver,et al.  The Metabolic basis of inherited disease , 1989 .